The normal newborn infant has inadequate homeostatic mechanisms for stabilizing the concentration of glucose in the blood (1, 2). Recent studies of carbohydrate metabolism in this age group have indicated a diminished responsiveness to small doses (30 jug per kg body weight) of exogenous glucagon (3, 4) and a slow rate of disappearance from the blood of either glucose or galactose administered intravenously (4, 5). Similar results have been observed in the premature infant (6). Glucose uptake by the tissues improves with a second dose and with age. The newborn infant is sensitive to exogenous insulin (5, 6), and insulin-like substances have been found in umbilical vein blood (7). We interpret the effects of the injection of either glucagon or galactose, which resulted in a prompt rise in the concentration of glucose in the blood, to indicate functional adequacy of the enzymes of the glycogen cycle in the liver of the newborn infant.
Methods
Sixty-one normal, newborn, full-term infants were studied after uncomplicated vaginal deliveries. Seventeen infants were born at the Cleveland Metropolitan General Hospital, the remaining forty-four at the University of Illinois, Research and Education Hospitals.
All infants were fasted for 12 hours and given glucose water for 12 hours and then dilute formula, 15 cal per 30 ml, for 24 to 72 hours-routine newborn care. Infants less than 6 hours of age were fasted from the time of delivery. Infants between 6 and 24 hours of age were fasted variable times from a minimum of 3 hours after a glucose feeding to a maximum of 12 hours after delivery. Infants older than 24 hours were fasted 3 to 4 hours before study. All infants tolerated the procedures well, showing no marked alterations in temperature, nor any circulatory, respiratory, or neurological abnormalities. The responses to fructose in these infants were measured after a rapid injection of 25%o fructose (1 g per kg body weight) given within a 2-to 4-minute period into a peripheral vein. Blood samples were obtained from punctures of the skin of the unwarmed heel. After 0.2-ml control samples were obtained before any injection, further samples were taken at 5, 10, 20, 30, 45, 60, 75, 90 , and 120 minutes after injection. To prevent glycolysis the capillary blood samples were either precipitated immediately with barium hydroxide and zinc sulfate or transferred to sodium fluoride solutions (0.6 mg per tube). Separate 0.1-ml samples were precipitated directly with trichloroacetic acid for the lactic acid determinations.
The infants were grouped according to age and test, as indicated in Table I . Group I infants received fructose only. Group II infants were given 3 ,Ag per kg of epinephrine subcutaneously followed by 300 ,ug per kg of glucagon intravenously. Samples of capillary blood were obtained at 0, 15, and 30 minutes when a fructose tolerance was superimposed as described above. Group III infants were given fructose intravenously. Capillary blood samples were obtained at 0, 5, 10, and 15 minutes, at which time an iv galactose tolerance (1 g per kg of a 25%o solution) was superimposed. Group IV infants were given the galactose initially and the fructose at 15 minutes. Group V infants were initially given fructose intravenously. After the 90-minute blood sample, an (11) . Hexose in the (12) . (Figures 1, 2 The levels of lactate in the blood were similar in both groups. The rates of fructose disappearance from the blood of these infants (Groups Ila, c) were similar to those obtained in infants (Groups Ia, c) given fructose alone. The iv injection of galactose (Group IVb) resulted in a prompt rise in blood glucose from 49 mg per 100 ml to 84 mg per 100 ml (Figure 4a,  d) . The superimposition of a fructose tolerance at 15 minutes resulted in a plateau in the level of glucose in the blood for 20 minutes, then a slight decline to 77 mg per 100 ml at 60 minutes, with a return to prefructose administration values of 85 mg per 100 ml for the remaining time of observation (Figure 4d ). When fructose was administered before galactose (Group IMIb), the rise in the concentration of glucose in the blood usually observed after galactose administration was delayed for 30 minutes (Figure 4c) .
A second injection of fructose, given 90 minutes after the initial fructose infusion (Group Va) during the phase when the concentration of glucose in the blood was rising, did not result in a prompt fall in the level of glucose in the blood. Instead, an initial rise in glucose concentration was observed (Figure 4b) . The clearly related directly to either the first or second fructose injectioni. The rate of fructose disappearance from the blood after the second dose was similar to the rate after the first injection.
Discussion
The physiological mechanismis resulting in the fall in the concentration of glucose in the blood associated with the rapid iv injection of fructose (Figure 1 ) may be related to an increase in tisstue uptake of glucose, a decrease in hepatic outplut, or a combination of both. There is evidence suggesting that the hypoglucosemia is not due to increased peripheral uptake. Fructose injected directly into the pancreatic artery of the dog does not produce hypoglucosemia, suggesting that fructose does not stimulate the release of insulini (13) . Although the infusion of fructose in nornmal men increases the rate of disappearance of ani exogenous glucose load, an increase in insuliln-like activity in the serum could not be detected (14) . The levels of insulin in the blood decrease concurrently with those of glucose after the administration of fructose to patients with hereditary fructose intolerance (15, 16) . Furthermore, studies of iv glucose and tolbutamide tolerances as well as leucine tolerances in newborn infants indicate a delayed or slow glucose disappearance from the blood, suggesting a failure or delay of pancreatic insulin release (5-7).
The data from the combined epinephrine-glucagon and fructose studies (Figure 3 ) indicate an inhibition of hepatic release of glucose by intravenously administered fructose. Glucagon stimulates hepatic glycogenolysis, and epinephrine, in addition, inhibits peripheral glucose uptake in muscle, resulting in a rise in the concentration of glucose in the blood. Previous studies have indicated that these hormones, alone or in combinationl, result in a characteristic sustained rise in the level of glucose in the blood in newborn infants (3, 4, 6) . In contrast, the responses of older infants and adults are of significantly shorter duration. Thus the fall in the level of glucose in the blood after glucagon and fructose administration must be interpreted to indicate a cessation of hepatic glucose output.
The rate of disappearance of intravenously administered fructose from the blood of the newborn infant is significantly slower than that in older infants and adults (Table II, Figure 2 ).
The adult clears fructose at a rate of 3.4 to 3.8%o per minute, assuming first order kinetics. In contrast, the mean rate in infants under 6 (4) (5) (6) .
The transient decreased uptake of frtuctose by tissues and the associated inhibition of glucose release by the newborn's liver may be analogous to the recently described syndrome of hereditary fructose intolerance (15) . Individuals with this disease respond to fructose, oral or injected, with a delayed fructose disappearance from the blood associated with a prompt and persistent hypoglucosemia, often associated with severe symptoms. Biopsy of the liver has indicated an absence of fructose-1-phosphate aldolase in several such patients ( 18) . Thus an accumulation of fructose-1-phosphate and fructose might be expected in the livers of such individuals.
The effect of administered fructose on the concentration of glucose in the blood may be influenced by factors other than the age of the subject. The mode of administration and dose of fructose may be important. For example, when fructose (0.5 g per kg) was given to adults during a continuous infusion lasting 30 to 60 minutes, no depression of the level of glucose in the blood was observed at the end of the infusion (19) . In contrast, when the time of injection of a comparable dose was shortened to 10 minutes, a transient hypoglucosemia was found in association with the higher concentrations of fructose attained in the blood (20) .
Although the human placenta is capable of fructose secretion in vitro, only low concentrations of fructose (less than 10 mg per 100 ml) have been measured in mixed umbilical cord blood (21) . Unlike the sheep and goat, man is nonfructogenic. Substrate induction of enzyme activity necessary for fructose metabolism is therefore unlikely to occur prenatally.
The studies reported suggest that there is in the full-term human infant, in the initial hours after birth, an adaptation of hepatic enzymes to metabolize exogenously administered fructose. Schapira, Schapira, and Dreyfus have reported recently on diminished fructose aldolase activity in a few human fetal liver samples (22) . WValker has found absent or diminished hepatic frtictokinase in three nonfructogenic species in the first 7 to 10 days after birth (23) . He also showed a diminished fructose disappearance rate from the blood of the newborn rabbit, which had decreased enzyme activity in the liver.
The invariable rise in lactate in the blood of infants of all age groups studied is inexplicable. A diminution of glucose-6-phosphatase activity such as occurs in type I glycogen storage disease would be associated with a rise in lactate and a fall in glucose. The failure to demonstrate a lessening of the lactate rise in older infants in whom hypoglucosemia was diminished makes this enzymatic defect unlikely. Our studies do not provide sufficient data to warrant speculation concerning alternative mechanisms such as inhibition of gluconeogenesis by fructose. The possibility of a peripheral tissue origin for the lactate must also be considered.
Possible mechanisms for the fructose-induced hypoglucosemia include the inhibition of phosphoglucomutase by fructose-i-phosphate and the inhibition of glycogenolysis or glucose-6-phosphatase. The administration of galactose intravenously in three patients with hereditary fructose intolerance resulted in a prompt rise in the level of glucose, previously depressed by fructose (16) . This would indicate that inhibition of phosphoglucomutase and glucose-6-phosphatase is unlikely. Our studies in infants under 6 hours of age are compatible with this interpretation. Additional support for the hypothesis is obtained from the results of the double fructose tolerance tests, which suggest that glucose-6-phosphatase is not inhibited by fructose administration. The low levels of glucose observed after fructose administration could be explained by an inhibition of glycogenolysis.
Summary
The rapid iv admiiinistration of fructose to normal newborn infants results in a prompt transient depression of the concentration of glucose in the blood. This is most evident in infants less than 6 hours of age but occurs in all age groups with rapid infusion.
The rate of disappearance of fructose from the blood diminishes for infants less than 24 hours of age. The rate of disposal of fructose increases with age.
When fructose is administered to infants after epinephrine-glucagon stimulation, the rise in the concentration of glucose in the blood is immediately suppressed and a decline occurs. We interpret this to indicate that fructose inhibits the release of glucose from the liver; combined galactose-fructose tolerance studies further substantiate this conclusion.
